ISPE Announces 2009-2010 Board of Directors
- Posted on 29 October 2009
ISPE has announced the results of its 2009-2010 International Board of Directors election.
Alan Mac Neice, chairman – Mac Neice was recently the project director for Biologics at Elan’s Biopharmaceutical Science’s campus in Ireland.
Andre Walker, vice chairman – Walker is the director of Manufacturing Engineering for Biogen Idec’s Commercial and Clinical Operations in Cambridge, Massachusetts, US, with responsibility for all GMP equipment, utilities, metrology, and validation.
Dr Arthur (Randy) Perez, treasurer – Dr Perez is the Executive Expert of IT Quality Assurance for Novartis Pharmaceuticals.
Dr Charlotte Enghave Fruergaard, secretary – Dr Fruergaard is a senior consultant in the Finished Product Department at NNE Pharmaplan in Denmark.
Damian Greene, director – Greene works for Pfizer Global Manufacturing in New York, US.
Winnie Cappucci, director – Cappucci is currently a member of ISPE’s Good Automated Manufacturing Practice (GAMP) Americas Steering Committee.
Doyle R Johnson, director – Johnson currently serves as consultant at CDI Life Sciences, working on Genzyme's Cell Culture Expansion Project in Framingham, Massachusetts, US.
Andrzej Szarmanski, director – Szarmanski is Quality Director at Polpharma SA, a European pharmaceutical manufacturer involved in manufacture of non-sterile and sterile pharmaceutical products as well as active pharmaceutical ingredients with headquarters in Poland.
Morten Stenkilde, director – Stenkilde is currently quality director at Novo Nordisk’s insulin filling plant in Tianjin, China.
Antonio Buendia, director – Buendia is currently the project engineering manager for Eli Lilly and Company’s Alcobendas, Spain facility.
